
29/09/2025
Israeli TruLeaf Medical completed the first stage of a first-in-human trial involving a novel approach to heart valve replacement.
The company emphasized the significance of this milestone for patients worldwide who are unable to undergo either open-heart surgery or existing transcatheter therapies.